Impact of Email Reminders on No-Show Rates for Appointments in an Urology Department

November 2, 2023 updated by: Diego Santillan, Hospital Italiano de Buenos Aires

Impact Analysis of Email Reminders on No-Show Rates in Scheduled Ambulatory Appointments in the Urology Department of Hospital Italiano de Buenos Aires

In this observational study, the investigators will analyze all patients who have scheduled appointments in the Urology Department from twelve months before the start date of the e-mail reminder dispatch (01/02/2023) to twelve months after (01/01/2022 to 31/12/2023). The investigators will divide them into two groups based on whether they have received the reminder or not. The investigators are going to compare the rate of no-show rates in both groups and then obtain the relative risk of the association between appointment reminders and no-show rates.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

JUSTIFICATION

The Outpatient Department and the Medical Informatics Department of the Hospital Italiano de Buenos Aires (HIBA) designed a joint strategy based on e-mail reminders for scheduled outpatient appointments. Patients who have an appointment (either face-to-face or teleconsultation) scheduled with a doctor at the Hospital receive an e-mail at the time of their request as well as 14 days and 48 hours before the appointment, reminding them of the appointment time and the place where they have to go. In addition, a button has been added to the e-mail so that the patient can click on it and cancel it directly in a simple way.

The possibility of canceling the appointment in the same reminder is also intended to have an impact on those who, without having forgotten their appointment, have to or want to miss it, can cancel it and thus leave the appointment free for another patient who needs it.

It seems that any type of reminder would be associated with a decrease in the no-show rate. However, it is questionable whether published figures are transferable to our setting. The variability of contexts and populations can affect the magnitude of the effect of an intervention.

After reviewing the literature, no studies were found analyzing appointment reminders and no-show rates in our country, so the investigators propose to conduct a study evaluating this impact in the Urology Department of HIBA. Although a clinical trial could be considered and the sending of reminders could be randomized, by the time the investigators decided to carry out this research, the intervention had already been implemented in all departments.

RESEARCH QUESTION

Is the e-mail reminder of a scheduled outpatient appointment to the Urology Department of HIBA effective in reducing no-show rates in patients over 18 years old?

SELECTION AND SAMPLE SIZE

During the year 2022, the Urology Department of Hospital Italiano de Buenos Aires (HIBA) performed approximately 29000 appointments in the Central Hospital and 11500 appointments in the Italian Hospital of San Justo, giving a total of 40500 appointments including spontaneous overtime and Spontaneous Demand appointments. The estimated weekly average is 779 appointments. Currently, in the Urology Service of HIBA, there is approximately a 21% no-show rate in scheduled outpatient appointments.

The investigators believe that achieving a 25% relative reduction in the proportion of no-show rates through the reminder system would be clinically relevant, i.e. from a 21% baseline no-show rate to 16%.

Using both STATA and the sample calculation tool provided free of charge by the University of San Francisco, the investigators estimated that the total N needed to estimate the calculated difference in no-show rates between groups is 1892 appointments (946 appointments per group). The parameters used were as follows: alpha (two-tailed)= 0.05, Beta= 0.20; q1 (proportion of appointments exposed)= 0.50; P0 (baseline risk of no-show rate in the unexposed group)= 0.21 and P1 (estimated risk in the exposed group)= 0.16.

The number of appointments requested before and after the implementation of the reminders is enough to test the study hypothesis.

DATA COLLECTION INSTRUMENT

For our study, the investigators will use secondary databases requested from the Department of Health Informatics after approval of the protocol by the bioethics committee of our institution. Because appointment management is centralized in a single data repository, all data corresponding to patients and appointment requests can be obtained from the entire HIBA electronic health system.

PLAN FOR DATA ANALYSIS AND REPORTING OF RESULTS

An individual approach will be used to evaluate the effect of the intervention on no-show rates. The unit of analysis is the assigned appointment. Due to the nature of the exposure and the implementation of the reminder system, all appointments before the implementation date correspond to unexposed appointments, and all appointments assigned after the implementation date correspond to exposed appointments.

Quantitative variables will be described with their absolute and relative frequency in percentage. Quantitative variables will be presented as mean and standard deviation or median and interquartile range according to the observed distribution.

For the calculation of the rates of no-shows and canceled appointments, the count of no-shows or canceled appointments, respectively, will be used as the numerator. For the no-show rate, the denominator used is the number of appointments not canceled, as is common for presenting this indicator in the literature. In the rate of canceled appointments, the total number of requested appointments will be used as the denominator. In both cases, only appointments that meet the inclusion criteria and none of the exclusion criteria during the same period will be used. The 95% CI (Confidence Interval) estimated with the normal approximation will be presented for each of the rates because the proportions are sufficiently large.

To test the null hypothesis of equality in the proportion of missed appointments between requested non-canceled appointments exposed to the reminder and requested non-canceled appointments not exposed to the reminder, a multivariate logistic regression model will be used. The investigators consider exposure to the reminder as the main exposure and no-show to the appointment as the outcome variable. Each patient will be considered as a conglomerate or cluster using robust estimators of the standard errors since the appointments of the same patient are more similar to each other than to the appointments of other patients. Time in days will be used as the adjustment covariate. The investigators will adjust for potential confounders considered relevant by the research team and the literature, which include sex, age, and medical coverage of the patient, time since the appointment request in days, time, day of the week and month of the appointment, place of care (Central Hospital, San Justo or Peripheral Center). The crude and adjusted ORs for missed appointments will be estimated with their 95%CI.

To test the null hypothesis of equality in the proportion of canceled appointments between requested appointments exposed to the reminder and canceled appointments among requested appointments not exposed to the reminder, the same methodology described for the previous objective will be used.

The effect of the intervention will be evaluated in pre-specified subgroups according to sex, age group, medical coverage, appointment time, day of the week, and month of the appointments, as well as according to place of care (Central Hospital, San Justo or Peripheral Center).

Probabilities of less than 0.05 will be considered statistically significant. Statistical analysis will be performed using STATA version 17 software (Texas USA).

HANDLING OF LOST DATA

The databases to be used in this analysis will contain a very low percentage of missing data. Because any missing data could be considered as missing completely at random, a complete case analysis will be used for the individual analysis.

BIASES AND LIMITATIONS OF THE STUDY

The limitations of our study, given the chosen methodology, will be mainly due to the lack of randomization of the exposure. This leads to confounding factors, which, although some will be considered a priori, cannot be considered in their totality since not all of them are known. On the other hand, the sample groups may not be balanced in terms of confounders, as may happen, for example, with time-dependent variables. However, since the intervention was implemented from a randomly defined point in time, the confounders are most likely to be balanced and, in addition, can eventually be adjusted through statistical methods.

While many retrospective studies are conducted based on incomplete or inaccurate information, many of the administrative variables in our study will be collected completely and automatically, with a standardized process that will remain stable throughout the study period. Unlike the administrative variables in the study, other variables, such as date of birth, may contain errors or incomplete data because although they are computerized, the data are originally uploaded by hospital administrators who are prone to error.

An additional limitation is all the unmeasured variables such as socioeconomic status and/or eHealth literacy of the individuals. Not all people open their e-mail every day and by not being able to measure who read the reminder the investigators may falsely believe that the intervention did not meet its objective when in fact what happens is that the patient did not open the e-mail and so was not exposed to the reminder. The investigatorsconsider it interesting in the future to compare our results with a reminder sent directly to the patient's cell phone via text messages or WhatsApp.

On the other hand, although the implementation of the intervention does not incur an additional cost to the institution for the aforementioned reasons, the investigators will not evaluate whether the intervention obtains any economic return.

Another limitation of our study is that the investigators will not evaluate the acceptability of the reminder by the users. If given a choice, it is possible that patients would choose other types of reminders according to personal preferences.

Nor will the investigators be able to estimate the impact of the intervention regarding teleconsultations, since these will be excluded from the analysis.

As far as external validity is concerned, the results obtained may not be extrapolated to other healthcare centers that do not have the structure of our hospital. To send e-mail reminders to all patients, it is necessary to have an electronic system that combines and processes information from the electronic medical record and the scheduling system and to coordinate it with a mass mailing system to be able to do it automatically. Otherwise, it is necessary to have human resources to do all this, which may not be cost-effective.

Last but not least, it is worth mentioning that since the intervention studied has two components (the reminder itself that prevents forgetfulness and the facilitator of appointment cancellation), it is not possible to estimate the effect of each component of the intervention separately.

EXPECTED IMPACT

The intervention is expected to decrease the no-show rate by 25% (or, in other words, to bring the no-show rate down to 16%) and the average waiting time for an appointment by at least one day. In addition, it is expected to increase the number of cancellations by 20%.

RESOURCES AND ESTIMATED BUDGET

The needed resources are available to complete this work. In no case will this study represent any additional cost for the patients or their medical coverage. The HIBA Medical Informatics Department already has a mass mailing system, so sending reminders does not require any financial investment or additional human resources.

The team in charge of the research and in charge of searching, processing, and analyzing the information has enough protected time during the working day to be able to complete the study within the stipulated deadlines.

ETHICAL CONSIDERATIONS

This study protocol has already been approved by our Hospital's Bioethics Committee: IRB (Institutional Review Board) Nº 6878

Study Type

Observational

Enrollment (Estimated)

1892

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

The target population of the study corresponds to scheduled outpatient appointments at the urology department. The accessible population are the appointments requested for care in the Urology Deparment of HIBA, with an assigned date between January 1, 2022 and December 31, 2023 inclusive (24 months in total).

Description

Inclusion Criteria:

  • We will include all patients over 18 years who have been assigned appointments or overappointments, scheduled or with note, in the Urology Department of HIBA between January 1, 2022 and December 31, 2023.

Exclusion Criteria:

  • Teleconsultation appointments and face-to-face consultations made through spontaneous overappointments or spontaneous demand will be excluded. The latter two cases are not considered to be appointments assigned to the patient prior to the consultation, but are assigned at the same time the patient presents his or her request. The electronic information system has no way of knowing in advance that this patient is going to be seen and therefore has no way of sending a reminder.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Pre-Intervention
Patients who have a medical appointment with a urologist in HIBA but did not receive any reminder.
Post-Intervention
Patients who have a medical appointment with a urologist in HIBA but did receive an email reminder of the appointment.
Behavioral: E-Mail Reminder
Patients who have an appointment (either face-to-face or teleconsultation) scheduled with a doctor at the Hospital receive an e-mail at the time of their request as well as 14 days and 48 hours prior to the appointment, reminding them of the appointment time and the place where they have to go. In addition, a button has been added to the e-mail so that the patient can click on it and cancel it directly in a simple way.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Proportion of scheduled appointment no-show rate
Time Frame: 14 days
Proportion of no-show outpatient appointments
14 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Proportion of scheduled appointment cancelations
Time Frame: 14 days
Proportion of canceled outpatient appointments
14 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Hospital Italiano de Buenos Aires

Investigators

  • Study Director: Diego H Giunta, PhD, Hospital Italiano de Buenos Aires

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2022

Primary Completion (Estimated)

December 31, 2023

Study Completion (Estimated)

March 30, 2024

Study Registration Dates

First Submitted

October 29, 2023

First Submitted That Met QC Criteria

October 29, 2023

First Posted (Actual)

November 2, 2023

Study Record Updates

Last Update Posted (Actual)

November 7, 2023

Last Update Submitted That Met QC Criteria

November 2, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 6878

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Reminder Systems

Clinical Trials on E-Mail Reminder

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Argentina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe